Aids Healthcare Foundation [Ahf] Opposition, Lenacapavir, (202017010006)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
AIDS HEALTHCARE FOUNDATION [AHF] opposition, Lenacapavir, (202017007904)
Countries: India Date: 2025
-
LOCOST opposition, Lenacapavir, (IN201917006277)
Countries: India Date: 2025
-
AIDS ACCESS FOUNDATION AND THAI NETWORK FOR PEOPLE WITH HIV/AIDS opposition, Dolutegravir/Abacavir/Lamivudine , (TH1201003753)
Countries: Thailand Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, lopinavir/ritonavir (LPV/r) , (339/MUMNP/2006)
Countries: India Date: 2007
-
Cipla Ltd. opposition, lopinavir/ritonavir (LPV/r) , (726/MUMNP/2009 (Divisional of 339/MUMNP/2006))
Countries: India Date: 2010
-
Matrix Laboratories Ltd. opposition, lopinavir/ritonavir (LPV/r) , (2474/DELNP/2009 (Divisional of 339/MUMNP/2006))
Countries: India Date: 2010
-
Ranbaxy Laboratories opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)
Countries: India Date: 2005
-
Cipla Ltd. opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)
Countries: India Date: 2008
-
Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)
Countries: India Date: 2011
-
Indian Network of People Living with HIV/AIDS (INP+) and Delhi Network of Positive People (DNP+) opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)
Countries: India Date: 2006